Showing results (1041-1050 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|September 13, 2019
Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical TrialTakayuki Yoshino, Takeharu Yamanaka, Eiji Oki, et al.
JAMA Oncology|February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical TrialOtto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
JAMA Oncology|September 6, 2019
Evaluation of Reproducible Research Practices in Oncology Systematic Reviews With Meta-analyses Referenced by National Comprehensive Cancer Network GuidelinesCole Wayant, Matthew J Page, Matt Vassar
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
JAMA Oncology|October 28, 2016
Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical TrialsTahira Devji, Oren Levine, Binod Neupane, et al.
JAMA Oncology|December 6, 2016
Axillary Nodal Management Following Neoadjuvant Chemotherapy: A ReviewMelissa Pilewskie, Monica Morrow
JAMA Oncology|December 6, 2016
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical TrialManish A Shah, Yung-Jue Bang, Florian Lordick, et al.
JAMA Oncology|December 9, 2016
Immune Response to HPV16 E6 and E7 Proteins and Patient Outcomes in Head and Neck CancerHeather H Nelson, Michael Pawlita, Dominique S Michaud, et al.
JAMA Oncology|December 23, 2016
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical TrialJoanne B Weidhaas, Jonathan Harris, Dörthe Schaue, et al.
JAMA Oncology|December 16, 2016
Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical TrialElizabeth L Barry, Janet L Peacock, Judy R Rees, et al.
Pageof 161